Suppr超能文献

Osimertinib induced adverse cardiac events: a case report.

作者信息

Lu Shang-Xin, Xing Yun-Li, Miao Ye, Zhang Xiao-Jie, Li Hong-Wei

机构信息

Department of Geriatrics, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Radiology Department, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

出版信息

J Geriatr Cardiol. 2023 Sep 28;20(9):702-706. doi: 10.26599/1671-5411.2023.09.006.

Abstract
摘要

相似文献

1
Osimertinib induced adverse cardiac events: a case report.
J Geriatr Cardiol. 2023 Sep 28;20(9):702-706. doi: 10.26599/1671-5411.2023.09.006.
2
Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Events Reporting System (FAERS).
JACC CardioOncol. 2019 Dec 17;1(2):172-178. doi: 10.1016/j.jaccao.2019.10.006. eCollection 2019 Dec.
4
Osimertinib induced cardiac failure and QT-prolongation in a patient with advanced pulmonary adenocarcinoma.
J Oncol Pharm Pract. 2022 Jun;28(4):989-994. doi: 10.1177/10781552211073823. Epub 2022 Jan 17.
5
Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer.
Onco Targets Ther. 2022 Apr 11;15:407-410. doi: 10.2147/OTT.S315385. eCollection 2022.
6
Intestinal Haemorrhage and Colitis Induced by Treatment With Osimertinib for Non-Small-Cell Lung Carcinoma: A Case Report.
Front Pharmacol. 2022 Apr 5;13:854277. doi: 10.3389/fphar.2022.854277. eCollection 2022.
7
Acute Lower Extremity Arterial Thrombosis Associated with Osimertinib-Induced Erythrocytosis.
Am J Case Rep. 2021 Sep 7;22:e932252. doi: 10.12659/AJCR.932252.
8
[Pulmonary manifestations induced by osimertinib].
Rev Mal Respir. 2022 Jan;39(1):62-66. doi: 10.1016/j.rmr.2021.12.002. Epub 2021 Dec 27.

引用本文的文献

1
Real-World Data on Osimertinib-Associated Cardiac Toxicity.
J Clin Med. 2025 Mar 5;14(5):1754. doi: 10.3390/jcm14051754.

本文引用的文献

1
Fatal ventricular arrhythmias after osimertinib treatment for lung adenocarcinoma: a case report.
J Geriatr Cardiol. 2023 Mar 28;20(3):242-246. doi: 10.26599/1671-5411.2023.03.009.
3
Heart Failure Associated With the Epidermal Growth Factor Receptor Inhibitor Osimertinib.
JACC CardioOncol. 2020 Mar 17;2(1):119-122. doi: 10.1016/j.jaccao.2020.01.003. eCollection 2020 Mar.
4
Cardiac Adverse Events in -Mutated Non-Small Cell Lung Cancer Treated With Osimertinib.
JACC CardioOncol. 2020 Mar 17;2(1):1-10. doi: 10.1016/j.jaccao.2020.02.003. eCollection 2020 Mar.
5
Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Events Reporting System (FAERS).
JACC CardioOncol. 2019 Dec 17;1(2):172-178. doi: 10.1016/j.jaccao.2019.10.006. eCollection 2019 Dec.
6
Osimertinib-Induced Cardiomyopathy.
JACC Case Rep. 2020 Apr 1;2(4):641-645. doi: 10.1016/j.jaccas.2019.12.038. eCollection 2020 Apr.
8
Osimertinib-induced cardiac failure with QT prolongation and torsade de pointes in a patient with advanced pulmonary adenocarcinoma.
Int Cancer Conf J. 2020 Oct 15;10(1):68-71. doi: 10.1007/s13691-020-00450-2. eCollection 2021 Jan.
9
Expression and Function of the Epidermal Growth Factor Receptor in Physiology and Disease.
Physiol Rev. 2016 Jul;96(3):1025-1069. doi: 10.1152/physrev.00030.2015.
10
Osimertinib induced cardiomyopathy: A case report.
Medicine (Baltimore). 2020 Sep 25;99(39):e22301. doi: 10.1097/MD.0000000000022301.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验